Stay updated on Pembrolizumab in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page
- Check3 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer site version.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe study page now shows recruitment is closed. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Interventions label formatting along with the page revision tag were updated to v3.6.0.SummaryDifference0.4%

- Check25 days agoChange DetectedThe page shows a new revision tag v3.5.5, representing a minor metadata update to the ClinicalTrials.gov record.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the page, indicating a maintenance or update; the study information shown remains unchanged.SummaryDifference0.1%

- Check60 days agoChange Detected- The page now shows a new revision label (v3.5.3), replacing the previous v3.5.2. This indicates a minor update to the document.SummaryDifference0.1%

- Check75 days agoChange DetectedSite software version updated from v3.5.0 to v3.5.2. No user-facing changes to study content or page structure are evident.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.